DOCN Drops 22% in a Week While an Activist Trims and Piper Upgrades on the Dip

DigitalOcean fell 22.4% in the past week to $99.48, a steeper slide than most of its closest peers: CRWV dropped 20%, APLD lost 14%, and AKAM gave back 10%, making DOCN the worst performer in its immediate peer group over the period.

Short interest has eased modestly from last week's peak but remains elevated. The short book is at 11.5% of the free float, around 10.5 million shares, down about 4% from the prior week after reaching close to 11.9% when the previous note was filed on October 14. The month-on-month picture remains pointed: that is still 25% more short exposure than late September, when the short book sat near 8.4 million shares. Days to cover of 3.6 give the position real weight. Yet the lending market offers no support to a squeeze thesis. Availability is wide, with roughly 744% of short interest still available to borrow and a cost to borrow of just 0.51%. Bears have plenty of room to maintain or grow positions without any supply constraint. Options sentiment has softened very slightly from last week's defensive extreme, with the put/call ratio at 1.07, almost exactly in line with its 20-day average of 1.06, a notable change from mid-October when it touched the 52-week high of 1.13.

The Street picture has shifted in the past 24 hours. Piper Sandler upgraded DOCN to Overweight this morning while cutting its target from $142 to $126, a rare combination of upgraded conviction and lowered expectations that reflects both the depth of this week's selloff and continued uncertainty about the growth trajectory. That target sits at a 27% premium to Tuesday's close at $99.48. Further back, Oppenheimer raised its target to $220 on October 14, and Truist initiated at Buy with a $175 target in August, leaving the consensus mean price target at $176.20, a gap that is now unusually wide given where the stock is trading. The bull case centres on AI inference demand: Q2 revenue rose 29% year on year to $281 million, AI customer ARR jumped 212% to $234 million, and RPO tripled to $894 million. The bear case is that GPU depreciation, startup costs running at $20-25 million per MW, and customer graduation risk to hyperscalers mean the margin picture stays fragile even as topline growth looks compelling. On valuation, the forward price/earnings multiple has compressed sharply, down roughly 28 points over the past month to 56x, while EV/EBITDA has contracted to 17.6x. The EPS momentum factor remains constructive, ranking in the 76th percentile on a 90-day basis, but the forward earnings growth score sits near the bottom of the universe at the 3rd percentile.

Ownership adds another layer to this week's move. Access Industries, the activist filer on DOCN's 13D register, trimmed its stake from 17.87% to 15.86% in a filing dated August 6, a reduction of roughly two percentage points. Access remains by far the largest holder at 15.9% of shares, but the direction of the move is worth noting. As always with 13D/G disclosures, the stake is as last disclosed and positions can shift further without a new filing until the 5% threshold is crossed. On the passive side, JPMorgan Asset Management added meaningfully, reporting 10.2 million shares, an increase of 6.5 million shares to the September 30 quarter-end. Vanguard's headline group filing showed a full exit from above 5%, though separate Vanguard entities still report active positions. The CEO and CFO executed sales in September under pre-arranged 10b5-1 plans, planned disposals that carry less signal than discretionary transactions.

Earnings are scheduled for November 3, thirteen days away. The last print, in August, produced a one-day decline of 2.1% and a five-day loss of nearly 5%. With short interest still elevated at 11.5% of the float, an activist holder that has been reducing, and the stock now trading roughly 44% below the consensus mean price target, the November 3 report is the near-term reference point for whether the gap between Street expectations and current price starts to close or widens further.